
Smith & Nephew plc SNN
$ 33.48
1.06%
Annual report 2025
added 04-04-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSE |
Shares |
- |
Market Cap[1] |
$ 23.8 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 173.14 | -0.8 % | $ 13 B | Nasdaq Global Select Market,SPB | ||
|
Bio-Rad Laboratories
BIO
|
$ 279.25 | 0.63 % | $ 7.88 B | NYSE,SPB | ||
|
Alphatec Holdings
ATEC
|
$ 10.9 | -1.54 % | $ 1.64 B | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.17 | -0.41 % | $ 1.64 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | 0.84 % | $ 38 M | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.3 | -1.79 % | $ 124 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Bruker Corporation
BRKR
|
$ 37.59 | -1.03 % | $ 5.6 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 61.79 | 0.83 % | $ 91.5 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.89 | - | $ 1.15 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.0 | -3.86 % | $ 16.9 M | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 8.68 | -3.12 % | $ 246 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 24.12 | -1.19 % | $ 204 M | NYSE American | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.97 | 0.19 % | $ 375 M | Nasdaq Global Select Market,SPB | ||
|
Inogen
INGN
|
$ 6.33 | -4.95 % | $ 168 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 62.78 | -0.93 % | $ 3.42 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
LENSAR
LNSR
|
$ 5.7 | 4.4 % | $ 68.2 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 90.42 | -1.07 % | $ 12.2 B | NYSE,SPB | ||
|
Butterfly Network
BFLY
|
$ 4.11 | -0.96 % | $ 870 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 10.04 | 1.62 % | $ 360 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Myomo
MYO
|
$ 0.69 | -1.43 % | $ 28.9 M | NYSE American | ||
|
Inspire Medical Systems
INSP
|
$ 54.02 | -4.71 % | $ 1.59 B | NYSE,SPB | ||
|
CONMED Corporation
CNMD
|
$ 36.74 | -0.51 % | $ 1.14 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.11 | -1.8 % | $ 2.96 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.68 | 0.38 % | $ 122 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 77.87 | -1.62 % | $ 45.5 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.